Results 221 to 230 of about 162,405 (296)

Non-albumin proteinuria as a candidate biomarker of treatment response to finerenone in diabetic kidney disease: a real-world cohort study. [PDF]

Front Endocrinol (Lausanne)
Choi MS, Kim HW, Yu M, Lee M, Lee YH, Kang ES, Cha BS, Lee BW.   +7 more
europepmc   +1 more source

Multisystem developmental abnormalities and insulin resistance in ADTKD‐HNF1B with the p.E105K variant: A clinical conundrum

Diabetic Medicine, EarlyView.
Abstract Aims HNF1B variants cause autosomal dominant tubulointerstitial kidney disease (ADTKD‐HNF1B), but the phenotypic spectrum of variants of uncertain significance (VUS) remains incompletely defined. We aimed to characterise the multisystem phenotype associated with the HNF1B p.E105K variant and to examine the mechanism underlying insulin ...
YunZe Wang, KangChun Xu, PengFei Liu, Bin Wang, Yan Yang, ShanZhai Wei   +5 more
wiley   +1 more source

Kidney biopsy in patients with small kidneys: diagnostic yield and treatment modification in a retrospective cohort study. [PDF]

Ren Fail
Wang W, Chen X, Wang R, Yao L, Zhang L.
europepmc   +1 more source

The role of sex and ethnicity in the variability of estimated glomerular filtration rate (eGFR) in people with type 1 diabetes

Diabetic Medicine, EarlyView.
Exploring Sex and Ethnicity Differences in eGFR for People with Type I Diabetes. Abstract Aims To examine sex‐based differences in estimated glomerular filtration rate (eGFR) trajectories for people with type 1 diabetes (T1D) over 10 years and to test the hypothesis that sex and ethnicity interaction predicts eGFR decline.
Salma Ayis, Murat Ozdede, Luigi Gnudi, Thamer Alobaid, Panagiotis Pavlou, Anastasios Mangelis, Nikolaos Fountoulakis, Aicha Goubar, Janaka Karalliedde   +8 more
wiley   +1 more source

Impact of Bevacizumab Relative Dose Intensity and Treatment-Induced Proteinuria on the Efficacy of Trifluridine/Tipiracil Plus Bevacizumab in Metastatic Colorectal Cancer. [PDF]

Cancers (Basel)
Tsukida T, Shibutani M, Nakatani S, Tanda H, Seki Y, Kasashima H, Emoto M, Maeda K.   +7 more
europepmc   +1 more source

Efficacy and Safety of SGLT2 Inhibitors in Patients With Genetic Lipodystrophy: A Real‐Life Experience From a National Reference Network

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim Lipodystrophy syndromes are rare diseases with metabolic and cardiovascular consequences. This study explores the metabolic and renal effects of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in patients with genetic lipodystrophy. Patients and Methods Patients with familial partial lipodystrophy (n = 57) or congenital generalised ...
Léna Robert, Ines Belalem, Corinne Vigouroux, Hippolyte Dupuis, Marie Christine Vantyghem, Mathilde Simonson, Estelle Nobecourt, Héléna Mosbah, Sophie Beliard, Stéphanie Jellimann, Sonja Janmaat, Camille Vatier, Sophie Lamothe   +12 more
wiley   +1 more source

Multi‐Dimensional Barriers for Work Productivity and Possible Solutions to Overcome Presenteeism in Young‐Onset Diabetes: A Mixed‐Methods Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Young‐onset non‐type 1 diabetes (YOD, age‐at‐diagnosis ≤ 40) is associated with poor physical and mental health, presenteeism and productivity loss. We examined patient‐perceived barriers to work productivity and key enablers to reduce presenteeism. Materials and Methods In this mixed‐methods study, we utilized validated questionnaires to
Kelly T. C. Wong, Jason D. C. Yin, Sunny C. S. Chan, Nga Sze Wong, Chun‐Kwan O, Yiming Dai, Yuzheng Zhang, Marques S.N. Ng, Risa Ozaki, Ronald C. W. Ma, Alice P. S. Kong, Andrea O. Y. Luk, Elaine Y.K. Chow, Juliana C. N. Chan, Juliana N. M. Lui   +14 more
wiley   +1 more source

Role of Omega-3 Fatty Acids in IgA Nephropathy: An Updated Review of Mechanisms and Evidence. [PDF]

J Clin Med
Taskapan H, Kugathasan L, Faruque L, Sikaneta T, Tam P.   +4 more
europepmc   +1 more source

Dyslipidaemia, Chronic Kidney Disease and Diabetes Mellitus: A Triple Threat to Cardiovascular Health

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Diabetes mellitus (DM) and chronic kidney disease (CKD) frequently coexist and together create a ‘triple threat’ with dyslipidaemia, enhancing the risk for cardiovascular morbidity and mortality. Diabetic kidney disease (DKD) leads to altered lipid metabolism through insulin resistance, inflammation and oxidative stress resulting in an ...
Ann S. Forrest, Priyanka Majety, Stéphanie B. Mayer, Om P. Ganda   +3 more
wiley   +1 more source

Durvalumab-associated nephrotic syndrome and organizing pneumonia: a case report. [PDF]

CEN Case Rep
Nawata T, Shibuya M, Asami-Noyama M, Uesugi N, Sano M.   +4 more
europepmc   +1 more source